Premium
On the Hydrolysis Mechanism of the Second‐Generation Anticancer Drug Carboplatin
Author(s) -
Pavelka Matěj,
Lucas Maria Fatima A.,
Russo Nino
Publication year - 2007
Publication title -
chemistry – a european journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.687
H-Index - 242
eISSN - 1521-3765
pISSN - 0947-6539
DOI - 10.1002/chem.200700887
Subject(s) - carboplatin , chemistry , density functional theory , molecule , hydrolysis , activation energy , computational chemistry , decomposition , ligand (biochemistry) , reaction mechanism , organic chemistry , cisplatin , medicine , biochemistry , surgery , receptor , chemotherapy , catalysis
The hydrolysis reaction mechanisms of carboplatin, a second‐generation anticancer drug, have been explored by combining density functional theory (DFT) with the conductor‐like dielectric continuum model (CPCM) approach. The decomposition of carboplatin in water is expected to take place through a biphasic mechanism with a ring‐opening process followed by the loss of the malonato ligand. We have investigated this reaction in water and acid conditions and established that the number of protons present in the malonato ligand has a direct effect on the energetics of this system. Close observation of the optimised structures revealed a necessary systematic water molecule in the vicinity of the amino groups of carboplatin. For this reason we have also investigated this reaction with an explicit water molecule. From the computed potential‐energy surfaces it is established that the water hydrolysis takes place with an activation barrier of 30 kcal mol −1 , confirming the very slow reaction observed experimentally. The decomposition of carboplatin upon acidification was also investigated and we have computed a 21 kcal mol −1 barrier to be overcome (experimental value 23 kcal mol −1 ). We have also established that the rate‐limiting process is the first hydration, and ascertained the importance of a water molecule close to the two amine groups in lowering the activation barriers for the ring‐opening reaction.